Abstract

The National Advisory Committee on Immunization (NACI) has been asked for an opinion on the effectiveness of live attenuated influenza vaccine (LAIV) in children in light of recent data in the United States of America (USA) related to the 2013-2014 influenza season, and particularly whether NACI maintains its preferential recommendation for LAIV in children for the 2014-2015 season.

  • Recommendation
  • Americas
  • Canada
  • Influenza